A New Era for Epigenetic Epidemiology

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

R Waterland is supported by USDA/ARS (CRIS 3092-5-001-059), the Cancer Prevention and Research Institute of Texas (grant number RP170295), and the National Institutes of Health (grant number 1R01DK111522). Where authors are identified as personnel of the Baylor College of Medicine, Houston, TX, USA, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the Baylor College of Medicine, Houston, TX, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

R Waterland is supported by USDA/ARS (CRIS 3092-5-001-059), the Cancer Prevention and Research Institute of Texas (grant number RP170295), and the National Institutes of Health (grant number 1R01DK111522). Where authors are identified as personnel of the Baylor College of Medicine, Houston, TX, USA, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the Baylor College of Medicine, Houston, TX, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.